MedTrace Logo

tDCS and Aphasia Treatment

NCT01922245 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2020-08-14

No results posted yet for this study

Summary

This project will investigate the use of noninvasive brain stimulation in the form of tDCS (transcranial direct current stimulation) in conjunction with speech-language therapy, for the improvement of language production in stroke survivors with aphasia. The hypothesis is that anodal tDCS and speech-language therapy will facilitate improved outcomes compared to speech therapy alone.

Conditions

  • Aphasia

Interventions

DEVICE

Soterix 1x1 tDCS

Anodal and sham tDCS will be administered. All of the participants will also receive behavioral speech-language therapy.

Sponsors & Collaborators

  • Hunter College of City University of New York

    lead OTHER

Principal Investigators

  • Elizabeth E Galletta, PhD · Hunter College/City University of NY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01922245 on ClinicalTrials.gov